Cover Image

Assessing CYP2C19 Ontogeny in Neonates and Infants Using Physiologically Based Pharmacokinetic Models: Impact of Enzyme Maturation Versus Inhibition

The objective of this study was to develop pediatric physiologically based pharmacokinetic (PBPK) models for pantoprazole and esomeprazole. Pediatric PBPK models were developed by Simcyp version 15 by incorporating cytochrome P450 (CYP)2C19 maturation and auto‐inhibition. The predicted‐to‐observed p...

Full description

Saved in:

Bibliographic Details
Main Authors:	Peng Duan (Author), Fang Wu (Author), Jason N. Moore (Author), Jeffrey Fisher (Author), Victor Crentsil (Author), Daniel Gonzalez (Author), Lei Zhang (Author), Gilbert J. Burckart (Author), Jian Wang (Author)
Format:	Book
Published:	Wiley, 2019-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Combining data on the bioavailability of midazolam and physiologically‐based pharmacokinetic modeling to investigate intestinal CYP3A4 ontogeny
by: Trevor N. Johnson, et al.
Published: (2024)

Investigating Tacrolimus Disposition in Paediatric Patients with a Physiologically Based Pharmacokinetic Model Incorporating CYP3A4 Ontogeny, Mechanistic Absorption and Red Blood Cell Binding
by: Matthias Van der Veken, et al.
Published: (2023)

Unravelling bisphenol A pharmacokinetics using physiologically based pharmacokinetic modeling
by: Xiaoxia eYang, et al.
Published: (2015)

The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs
by: Shanna C. Trenaman, et al.
Published: (2021)

Ontogeny of CYP3A and UGT activity in preterm piglets: a translational model for drug metabolism in preterm newborns
by: Laura Buyssens, et al.
Published: (2023)

Physiologically based pharmacokinetic modeling to predict the pharmacokinetics of codeine in different CYP2D6 phenotypes
by: Yujie Yang, et al.
Published: (2024)

Role of farnesoid X receptor in establishment of ontogeny of phase-I drug metabolizing enzyme genes in mouse liver
by: Lai Peng, et al.
Published: (2016)

Pharmacokinetic interaction between rhynchopylline and pellodendrine via CYP450 enzymes and P-gp
by: Qingzhen Meng, et al.
Published: (2021)

Ontogeny and Phylogeny of Brain Barrier Mechanisms
by: Shane A. Liddelow
Published: (2016)

The Ontogeny of Cytochrome P450 Enzyme Activity and Protein Abundance in Conventional Pigs in Support of Preclinical Pediatric Drug Research
by: Joske Millecam, et al.
Published: (2018)

Physiologically based mechanistic insight into differential risk of valproate hepatotoxicity between children and adults: A focus on ontogeny impact
by: Yu‐Ting Huang, et al.
Published: (2023)

A commentary on the oceans - our ontogeny of eternity
by: Deepak Sarangi
Published: (2021)

Sexual Dimorphism of Size Ontogeny and Life History
by: Alina German, et al.
Published: (2020)

Making Blood: The Haematopoietic Niche throughout Ontogeny
by: Mohammad A. Al-Drees, et al.
Published: (2015)

Ontogeny Related Changes in the Pediatric Liver Metabolome
by: Christopher M. Wilson, et al.
Published: (2020)

Physiologically‐based pharmacokinetic modeling to predict drug interactions of lemborexant with CYP3A inhibitors
by: Takashi Ueno, et al.
Published: (2021)

Pharmacokinetics of the CYP3A4 and CYP2B6 Inducer Carbamazepine and Its Drug-Drug Interaction Potential: A Physiologically Based Pharmacokinetic Modeling Approach
by: Laura Maria Fuhr, et al.
Published: (2021)

High-altitude Hypoxia Influences the Activities of the Drug-Metabolizing Enzyme CYP3A1 and the Pharmacokinetics of Four Cardiovascular System Drugs
by: Junbo Zhu, et al.
Published: (2022)

Impact of polymorphisms in CYP and UGT enzymes and ABC and SLCO1B1 transporters on the pharmacokinetics and safety of desvenlafaxine
by: Sofía Calleja, et al.
Published: (2023)

Cardiorenal Effects of Kappa Opioid Peptides During Ontogeny
by: Wei Qi, et al.
Published: (2011)

Physiologically‐based pharmacokinetic modeling to predict CYP3A4‐mediated drug‐drug interactions of finerenone
by: Thomas Wendl, et al.
Published: (2022)

Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan
by: Jan Grzegorzewski, et al.
Published: (2022)

Physiologically‐Based Pharmacokinetic Modeling for the Prediction of CYP2D6‐Mediated Gene-Drug-Drug Interactions
by: Flavia Storelli, et al.
Published: (2019)

Spatiotemporal cellular dynamics and molecular regulation of tooth root ontogeny
by: Pengcheng Rao, et al.
Published: (2023)

Factors of postembryonic ontogeny: relationship with the effectiveness of tuberculosis chemoprophylaxis in children
by: K.I. Bodnia, et al.
Published: (2024)

Ontogeny of alkaline phosphatase activity in infant intestines and breast milk
by: Ye Yang, et al.
Published: (2019)

Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen
by: Ioannis Loisios-Konstantinidis, et al.
Published: (2020)

Physiologically based pharmacokinetic modeling of tacrolimus for food-drug and CYP3A drug-drug-gene interaction predictions
by: Helena Leonie Hanae Loer, et al.
Published: (2023)

Prediction of CYP-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Modeling: A Case Study of Salbutamol and Fluvoxamine
by: Lara Marques, et al.
Published: (2023)

Physiologically Based Pharmacokinetic (PBPK) Modeling of Clopidogrel and Its Four Relevant Metabolites for CYP2B6, CYP2C8, CYP2C19, and CYP3A4 Drug-Drug-Gene Interaction Predictions
by: Helena Leonie Hanae Loer, et al.
Published: (2022)

Investigation of CYP3A induction by PF‐05251749 in early clinical development: comparison of linear slope physiologically based pharmacokinetic prediction and biomarker response
by: Jian Lin, et al.
Published: (2022)

A Physiologically-Based Pharmacokinetic Model of Ruxolitinib and Posaconazole to Predict CYP3A4-Mediated Drug-Drug Interaction Frequently Observed in Graft versus Host Disease Patients
by: Bettina Gerner, et al.
Published: (2022)

Physiologically‐based pharmacokinetic modeling of quinidine to establish a CYP3A4, P‐gp, and CYP2D6 drug-drug-gene interaction network
by: Denise Feick, et al.
Published: (2023)

Book Review: Die Evolutione der Zahne: Phylogenie, Ontogenie, Variation
by: Michael Schultz
Published: (1999)

Transformation of berberine to its demethylated metabolites by the CYP51 enzyme in the gut microbiota
by: Zheng-Wei Zhang, et al.
Published: (2021)

A physiologically based pharmacokinetic model of clopidogrel in populations of European and Japanese ancestry: An evaluation of CYP2C19 activity
by: Janna K. Duong, et al.
Published: (2022)

Physiologically‐based pharmacokinetic modeling of dextromethorphan to investigate interindividual variability within CYP2D6 activity score groups
by: Simeon Rüdesheim, et al.
Published: (2022)

Physiologically‐based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population
by: Elizabeth J. Thompson, et al.
Published: (2024)

A Physiologically Based Pharmacokinetic and Pharmacodynamic Model of the CYP3A4 Substrate Felodipine for Drug-Drug Interaction Modeling
by: Laura Maria Fuhr, et al.
Published: (2022)

Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and Risperidone
by: Simeon Rüdesheim, et al.
Published: (2022)